Alba Health is a Danish-Swedish company focused on advancing child health through microbiome science. They specialize in analyzing infant gut health to provide actionable insights for improving immunity, metabolism, and overall well-being. Their work is supported by cutting-edge research collaborations with leading institutions like the University of Helsinki and COPSAC. Alba's efforts include the PREVENT Study, which investigates the relationship between infant gut microbiomes, lifestyle, and health outcomes during the first year of life. Families receive personalized reports and expert consultations to optimize their child’s health based on microbiome data, utilizing advanced metagenomic sequencing to ensure precision and scientific rigor.